U.S. to consider expanding Medicare drug price negotiation

Reuters: Business News Reuters: Business News

WASHINGTON/NEW YORK (Reuters) - The Trump administration is considering expanding Medicare's ability to negotiate the cost of drugs by giving private payers a role in setting the price of medicines administered in hospitals and doctors' offices, Health and Human Services Secretary Alex Azar said on Monday.

Reuters: Business News

Leave a Reply